Searched for
DRUG APPROVALS
US stocks: Summit shares drop after US FDA declines to approve lung cancer drugSummit Therapeutics faced a notable decline in share value following the FDA's ruling on ivonescimab, which revealed insufficient overall s...
Biocon gets USFDA nod for breast cancer biosimilar PebrilzoBiocon Ltd has announced receiving US FDA approval for their biosimilar Pebrilzo, which treats HER2-positive breast cancer. This milestone ...
This drug-development startup raised about $20 million; now its team builds OpenAI's life-sciences AI; here's what you need to knowOrchestra Bio is a San Francisco-based startup. It was founded by Ashoka Rajendra in 2022. The company's main aim is to develop AI tools to...
18 patent applications for HIV drug lenacapavir may delay affordable generics in IndiaGilead Sciences has filed 18 patent applications in India for lenacapavir, raising concerns among patient groups. They argue these applicat...
Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj JoshiThe government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered...
- US returns over $12 billion in oil proceeds to Venezuela since Maduro's ouster, report says
The Trump administration has reported returning over $12 billion in oil revenue to Venezuela as of September 30. Almost all funds from oil ...
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
Deepinder Goyal's $900 Temple wearable faces scrutiny over brain blood-flow claimsTemple, a new wearable device, claims to track blood flow to the brain and other health metrics. Indian doctors express concerns over the v...
Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
Who is Thomas Massie and why has he proposed impeachment proceedings against US Defence Secretary Pete Hegseth?Thomas Massie has proposed eight articles of impeachment against US Defence Secretary Pete Hegseth. The congressman from Kentucky has accus...
Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
NCLT approves Ashdan Properties' resolution plan for Sunblink Real EstateThe National Company Law Tribunal approved Ashdan Properties' resolution plan for Sunblink Real Estate, which involved significant creditor...
Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoYGland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. Th...
Scientists gave mice an existing asthma drug before exposing them to peanut extract; 95% were protected from severe allergic reactions in the experimentResearchers at Northwestern University found that the asthma drug Zileuton reduces allergic reactions in mice fed peanut extract. The study...
Govt plans instant ban on manufacturing of drugs failing key quality testsPharma companies could have their drug licenses suspended immediately if quality tests indicate failure. The health ministry's proposed cha...
Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...